Welcome To MiExpo Conference

Special Guests

Welcome To MiExpo Conference

Join The Innovators

CONFERENCE
Quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure reprehenderit voluptate velit esse. Excepteur sint uda occaecat cupidatat non proident, commodo sunt culpa qui officia deserunt mollit est laborum sed utm pers piciatis unde omnis iste dolor natus error sit ipsum.

Eabore etsu dolore magn aliqua enim ad minim veniam quis nostrud exercitas tion ullamco ipsum laboris.

Eabore etsu dolore magn aliqua enim ad minim veniam quis nostrud exercitas tion ullamco ipsum laboris.

Eabore etsu dolore magn aliqua enim ad minim veniam quis nostrud exercitas tion ullamco ipsum laboris.

MiExpo Business Forum Mission

We Explain How Institutions Can Tackle The Complexity Of The Market Today!

Veniam quis nostrud exercitation ullamco laboris nisi ut aliquip comdo sed conseqa irure dolorn reprehenderit voluptate velit excepteur sint occaecats aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla ipsum pariatur excepteur sint occaecat sed cupidatat.

Eiusmod tempor incididunt utn labore dolore magna aliquatenim
minim veniam quis nostrud.

Laboris nisi ut aliquip ex ea commodo conseqe ipsum dolor sit amet consectetur adipisicing.
Welcome To MiExpo Conference

Forum Schedule

  • Day 1 Friday - September 10th, 2021
  • Day 2 Saturday - September 11th, 2021
  • Optional Day 3 Sunday - September 12th, 2021
8:00 am
---
9:20 am

Opening session

Opening address

2021 Melanoma Summit overview
Dr Chris Boberg, Chair 2021 New Zealand Melanoma Summit Planning Committee and Co-Chair, MelNet

Patient challenge

Melanoma in the New Zealand cancer landscape
Professor Diana Sarfati, Chief Executive, Te Aho o Te Kahu - Cancer Control Agency

Quality Statements for Melanoma Care in New Zealand
Dr Richard Martin, Chair Melanoma Quality Statements Working Group

9:20 am
---
10:30 am

Session 1: Epidemiology and primary prevention

Epidemiological trends in melanoma
Professor David Whiteman, Senior Scientist and Deputy Director, QIMR Berghofer Medical Research Institute, Queensland, Australia

What is happening about sunscreens in New Zealand?
Jon Duffy, Chief Executive, Consumer New Zealand
Dr Louise Reiche, Dermatologist, Kauri Healthcare Palmerston North and Immediate Past President, New Zealand Dermatological Society Incorporated 

My story
Todd Muller, Patient representative

Questions and discussion
11.00 am
---
12.00 noon

Session 2: Early detection

Early detection saves lives: Our story
Chris and Judy Bailey, Patient representatives

The evolution of early detection, dermatoscopy and artificial intelligence
Professor Cliff Rosendahl, Course Coordinator of Master of Medicine (Skin Cancer) Programme, University of Queensland, Australia
Adjunct Associate Professor Amanda Oakley, Dermatologist, Waikato District Health Board

Questions and discussion

Professor Cliff Rosendahl kindly supported by Cancer Research Trust NZ
12.00 noon
---
12:30 pm

Session 3: Controversy of borderline lesions

Clinico-histological collaboration
Professor Cliff Rosendahl, Course Coordinator of Master of Medicine (Skin Cancer) Programme, University of Queensland, Australia
Dr Ben Tallon, Dermatologist, SKIN Dermatology Institute and Dermatopathologist, Pathlab, Tauranga
Dr Richard Massey, Pathologist and Director, Pathology Associates, Tauranga
Dr Michael Hitchcock, Pathologist and Clinical Lead, Anatomic Pathology Services, Auckland District Health Board

Questions and discussion

Professor Cliff Rosendahl kindly supported by Cancer Trust Research NZ
1:30 pm
---
2:45 pm

Session 4: Concurrent breakout session 1

Breakout 4A - New Zealand primary prevention and early detection initiatives
This session will highlight and discuss primary prevention and early detection initiatives underway in the sector. It will also discuss the New Zealand Skin Cancer Primary Prevention and Early Detection Strategy and its alignment with the Te Aho o te Kahu – Cancer Control Agency ‘Prevention Strategies’ report.

Breakout 4B - Dermatoscopy in action
In this session Professor Cliff Rosendahl will teach the basics of the ‘chaos and clues’ approach to dermatoscopy in diagnosing melanoma and will demonstrate its practical application to specific cases.

Professor Cliff Rosendahl kindly supported by Cancer Research Trust NZ

Breakout 4C - MelNet melanoma multi-disciplinary meeting: challenging cases
In this session, a multi-disciplinary panel will discuss the clinical management of a range of challenging or unusual cases of melanoma.

Breakout 4D - Upcoming research and innovations
Presenters whose submitted abstracts have been selected will provide snapshots of upcoming research and clinical innovations
3:15 pm
---
4:15 pm

Session 5: Paving the way for high quality, collaborative melanoma care

Waitemata District Health Board: a collaborative skin cancer care model

Nurse led dermatoscopy clinics: the way of the future?
Katy Doherty, Managing Director, Espy Skin, Auckland
Trish Baker, Managing Director, HealthBox NZ Ltd, Auckland

Serious Illness Conversation Guide
Jane Goodwin, Advanced Care Planning Facilitator and Registered Nurse, Canterbury District Health Board

4.15 pm
---
5.00 pm

Session 6: Concurrent breakout session 2

Breakout 6A - Pathology synoptic reporting and histology updatee
This session will update on progress towards consistent synoptic reporting for skin cancer.

Breakout 6B - New Zealand melanoma research and therapy special interest group
Intended for those involved or interested in being part of the Melanoma Research and Therapy Special Interest or those with an interest in research or therapy. Topic to be confirmed.

Breakout 6C - Serious Illness Conversation Guide
Using the Serious Illness Conversation Guide, this session will build on the plenary session to help develop skills and confidence in having difficult conversations with patients and their whanau.

Breakout 6D - GPs with a special interest in skin cancer
Intended for those who are part of or interested in joining New Zealand Skin Cancer Doctors. The session will provide an overview of New Zealand Skin Cancer Doctors and the work they do. It will also include a discussion of interesting dermatoscopic and surgical cases. Attendees are encouraged to bring along cases to discuss.
5.00 pm
---
5.15 pm

Session 7: Day one wrap up

Highlights and recommendations from breakout sessions and day one summary
5:15 pm
---
5:30 pm
8:00 am
---
9:30 am

Session 8: State of the art melanoma management

In situ melanoma - current best practice in New Zealand
Dr Andrew MacGill, Director, SkinCheck Northcote, Auckland and fully accredited member of New Zealand Skin Cancer Doctor Society 

Mohs surgery for melanoma
Dr Paul Salmon, Dermatologist, Skin Centre, Tauranga

Advances in the management of invasive melanoma
Dr Mark Faries, Surgical Oncologist, The Angeles Clinic and Research Institute, Los Angeles, USA

My story
Jeffery Dalley, Patient representative

Questions and discussion
10:00 am
---
12:00 noon

Session 9: Advanced melanoma management

My story
Tim Stephens, Patient representative

The future and evolution of adjuvant and neoadjuvant therapy
Dr Inês Pires da Silva, Medical Oncologist and Researcher Scientist at Melanoma Institute Australia, Westmead & Blacktown Hospitals, and The University of Sydney

The New Zealand situation
Dr Jody Jordan, Medical Oncologist, Hawke’s Bay District Health Board

Nurses care perspective on managing advanced melanoma
Jo Tuaine, Oncology Clinical Nurse Specialist, Southern District Health Board

My story

Questions and discussion
1:00 pm
---
1:40 pm

Session 10: Melanoma and genetics

Current status of molecular profiling of melanoma
Professor Grant McArthur, Head Molecular Oncology Laboratory, Peter MacCallum Cancer Centre and Executive Director, Victoria Comprehensive Cancer Centre, Melbourne, Australia

Questions and discussion
1:40 pm
---
2:30 pm

Session 11: The economics of the skin cancer epidemic

The public sector
Associate Professor Louisa Gordon, Group Leader Health Economics, QIMR Berghofer Medical Research Institute

The private sector
Dr Stephen Child, Chief Medical Officer, Southern Cross

Questions and discussion  

2:30 pm
---
3:15 pm

Session 12: Concurrent breakout session 3

Breakout 12A - Priorities for action – primary prevention
This session will workshop priorities for action for New Zealand that support primary prevention.

Breakout 12B - Priorities for action – early detection
This session will workshop priorities for action for New Zealand that support early detection.

Breakout 12C - Priorities for action – clinical management of advanced disease and research
This session will workshop priorities for action for New Zealand relating to the clinical management of advanced disease and research.
3:45 pm
---
5:00 pm

Session 13: Looking to the future of melanoma

Setting the priorities for action - recommendations from concurrent breakout session 3

Panel: The future of melanoma prevention, diagnosis, treatment, care and research

Questions and discussion

Wrap up, recommendations and closing remarks
Mr Gary Duncan and Dr Chris Boberg, Co-Chairs, MelNet
9:00 AM
---
9:15 AM
Professor Cliff Rosendahl

Dermatoscopy – What’s it all about (CR)

Professor Cliff Rosendahl will discuss how a dermatoscope helps you to diagnose what a skin lesion is and how to use your scope.
9:15 AM
---
9:30 AM
Professor Cliff Rosendahl

Basics of Revised Pattern Analysis (CR)

Professor Cliff Rosendahl will discuss the fundamentals of the dermatoscopic language, clarify terminology, and explain the basics of ‘Revised Pattern Analysis’,  a reproducible and systematic dermatoscopic method.
9:30 AM
---
10:15 AM
Professor Cliff Rosendahl

Rapid clinical recognition. Melanoma – in a blink (CR)

Professor Cliff Rosendahl will go through a series of images both dermatoscopic and clinical that will demonstrate “Type 1 thinking” to rapidly in a blink identify the “ugly duckling” / “outlier” as a suspicious lesion.
10:45 AM
---
11:30 AM
Associate Professor Amanda Oakley

Dermatoscopy common benign lesion (AO)

Associate Professor Amanda Oakley will discuss the important dermatoscopic features that facilitate confident recognition of the many benign lesions. This course has been developed to teach you how to recognize the most common benign lesions. The advanced course will expand your skills for more accurate dermatoscopic recognition of less common but important to know benign lesions.
11:30 AM
---
12:15 PM
Professor Cliff Rosendahl

Chaos & Clues: Part 1 (CR)

Professor Cliff Rosendahl will outline this most important algorithm for your clinical tool kit when dealing with pigmented lesions. ‘Chaos and clues’ facilitates rapid dermatoscopic recognition of melanomas and other suspicious pigmented lesions. The first half of the algorithm assesses for the presence of chaos and the second half assesses the presence of one or more key dermatoscopic clues. Cliff is the main author of  ‘Chaos and Clues’ and hence is well placed to clarify any of your questions. There will be interactive quizzes throughout.
1:15 PM
---
2:00 PM
Professor Cliff Rosendahl

Chaos & Clues: Part 2 (CR)

Professor Cliff Rosendahl: Chaos and Clues. Part 2
2:00 PM
---
2:45 PM
Associate Professor Amanda Oakley

Dermatoscopy of BCCs and SCCs – an introduction (AO)

Associate Professor Amanda Oakley will emphasise and outline the key dermatosopic features of SCCs and BCCs
3:15 PM
---
4:15 PM
Dr Andrew Macgill

Learning Quizzes (AM)

3:30 PM
---
4:15 PM
Associate Professor Amanda Oakley

Medical management of keratinocytic cancer (AO)

In this session, Associate Professor Amanda Oakley will discuss the medical management of keratinocytic cancer (ie BCCs and SCCs).
4:15 PM
---
4:45 PM
Professor Cliff Rosendahl

Clinical cases and discussion (CR)

Welcome To MiExpo Conference

Who’s Speaking

Robert Gates

Lead Speaker

Veniam quis nostrud exercitaon ullam laboris nis aliquip sed conseqal.

Amanda Tim

Lead Speaker

Veniam quis nostrud exercitaon ullam laboris nis aliquip sed conseqal.

Paul Wilson

Lead Speaker

Veniam quis nostrud exercitaon ullam laboris nis aliquip sed conseqal.

Benjamin Zara

Lead Speaker

Veniam quis nostrud exercitaon ullam laboris nis aliquip sed conseqal.

Welcome To MiExpo Conference

Get Your Tickets

Standard Pass
$1201 day
Eiusmod tempor incidunt etsu dolore magn aliquate nimads ullamco laboris nis sed ipsum lorem.
buy ticket
Flexible Pass
$2702 day
Eiusmod tempor incidunt etsu dolore magn aliquate nimads ullamco laboris nis sed ipsum lorem.
buy ticket
Business Pass
$3403 day
Eiusmod tempor incidunt etsu dolore magn aliquate nimads ullamco laboris nis sed ipsum lorem.
buy ticket
Premium Pass
$4601 week
Eiusmod tempor incidunt etsu dolore magn aliquate nimads ullamco laboris nis sed ipsum lorem.
buy ticket
Appreciate Our Kind Partners Sponsors & Exhibitors

Sponsors & Exhibitors

MiExpo Sumit Pictures & Videos Gallery

Get In Touch!

Veniam quis nostrud exercitation ullamco laboris nisi ut aliquip sed conseqa irure dolorn reprehenderit voluptate velit excepte occaecats aliquip ex ea commodo consequat.

    Welcome To MiExpo Conference

    Latest News

    Veniam quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comdo sed conseqa
    irure dolorn reprehenderit voluptate velit esse excepteur sint occaecats.

    Unique Digital Ideas to Learn Business

    Eabore dolore magn aliqua enim veniam quis nostrud exercitas reprehenderit […]

    read more

    Connecting People for MiExpo Summit

    Eabore dolore magn aliqua enim veniam quis nostrud exercitas reprehenderit […]

    read more

    National Geographic Society

    Eabore dolore magn aliqua enim veniam quis nostrud exercitas reprehenderit […]

    read more